Myriad Proteomics, Inc.

PositionPlayers - Thomas D. Ingolia - Brief Article

Thomas D. Ingolia, Ph.D. has joined Myriad Proteomics, Inc. as president and chief executive officer. After 13 years at Eli Lilly and Company, Ingolia held leadership roles as senior vice president and COO of Ontogeny. He brings critical experience to Myriad Proteomics...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT